The Three Generations of Incretin Peptide Research The progression from single to dual to triple agonist peptides represents a research trajectory that has played out in roughly ten years: Generation 1 Single GLP-1 Agonists (Semaglutide, Liraglutide, Exenatide) The first incretin peptides to reach broad clinical research were GLP-1 receptor agonists
When you arrive with three months of logged doses, symptoms, meals, and weight, plus clearer questions you have already thought through, the short appointment goes further
What is the typical research dose for GHRP-2 and ipamorelin
Monitoring: Track fasting glucose and, where possible, IGF-1, since GH influences both
Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), liraglutide, dulaglutide, all prescription